Get started
Work

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Year: 2017
Type: article
DOI: 10.1016/j.jtho.2017.01.022
Authors: Maria Q. Baggstrom, Mark A. Socinski, Xiaofei F. Wang, Lin Gu, Thomas E. Stinchcombe, Martin J. Edelman, Sherman Baker, Josephine Feliciano, Paul Novotny, Olwen Hahn, Jeffrey A. Crawford, Everett E. Vokes
Institutions: Washington University in St. Louis, University of North Carolina at Chapel Hill, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, VCU Massey Comprehensive Cancer Center, Mayo Clinic, University of Chicago, Duke Medical Center, Duke Cancer Institute
Language: English
Field: Medicine
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Ariad Pharmaceuticals, Celgene, University of Pittsburgh, Helsinn, Endocyte, Cardinal Health, National Institutes of Health, Genentech, EMD Serono, National Cancer Institute
Awards: Alliance Statistics and Data Management Center, Washington University/ Siteman Cancer Center Lead Academic Site, NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center, Cancer and Leukemia Group B Statistical Center, NCI NCTN-Network Lead Academic Site at UPCI, NCI National Clinical Trials Network-Network Lead Academic Participating Sites, Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site, NCI National Clinical Trials Network U10, Cancer and Leukemia Group B, NCTN Lead Academic Participating Sites Application, Alliance for Clinical Trials in Oncology Operations Center
OpenAlex ID: W2584858276
FWCI: 2.712
Cites: 13
Cited by: 37
Related to: 10